<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Study showes Duvaxyn IE-T Plus cross protects against Sydney/07 virus strain of equine influenza</title><link>/b/veterinary-news/posts/4994</link><description> Fort Dodge has announced that a challenge study has demonstrated the ability of Duvaxyn &amp;#174; IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Sydney/07 (H3N8) two weeks after a two dose primary course. This strain was responsible for</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>